ストックスクリーナーアプリを入手
10.95
5.28%
-0.61
アフターアワーズ：
12.14
1.19
+10.87%
Eloxx Pharmaceuticals Inc (ELOX) 最新ニュース
Price to sales forward of Eloxx Pharmaceuticals, Inc. – BOATS:ELOX - TradingView
Eloxx’s EXACT Study Puts Exaluren in Focus for Rare Kidney Disease Investors - TipRanks
ELOXEloxx Pharmaceuticals Inc Latest SEC Filings - Finviz
ELOX|Eloxx Pharmaceuticals Ord Shs|Price:11.750|Chg%:-0.25 - TradingKey
Enterprise value to revenue forward of Eloxx Pharmaceuticals, Inc. – NASDAQ:ELOX - TradingView
ELOX SEC FilingsEloxx Pharmaceut 10-K, 10-Q, 8-K Forms - Stock Titan
Eloxx Pharmaceuticals StockSaturday view on pipeline and business model - AD HOC NEWS
Coastlands (NASDAQ: ELOX) discloses 410,530 shares, 9.99% stake - Stock Titan
Domicilium group discloses 19.99% stake in Eloxx (NASDAQ: ELOX) - Stock Titan
Eloxx (ELOX) 10% holder swaps Pre-Funded Warrants into common stock - Stock Titan
Domicilium Real Estate Fund III (ELOX) details Eloxx stock and warrant stakes - Stock Titan
12 Health Care Stocks Moving In Wednesday's After-Market Session - Sahm
EcoR1, affiliates report ~9.9% holdings in Eloxx (NASDAQ: ELOX) - Stock Titan
Stonepine-affiliated holders report 403,228 shares in Eloxx (ELOX) — 9.9% stake - Stock Titan
Invus-led group holds 9.99% of Eloxx (ELOX) via shares and warrants - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Eloxx Pharmaceuticals: Shares Expected to Start Trading on Nasdaq Capital Market on June 9 >ELOX - Moomoo
ELOX Technical Analysis & ETF Price Forecast - Intellectia AI
ELOX Price Today: Eloxx Pharmaceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Eloxx Pharma (ELOX) Stock Analysis Report | Financials & Insights - Benzinga
Eloxx (NASDAQ: ELOX) CEO receives 328,833 performance-based stock options - Stock Titan
Eloxx Pharmaceuticals (ELOX) director receives 13,587 stock options grant - Stock Titan
Eloxx (ELOX) director Steven Rubin receives 4,018 stock options at $11 strike - Stock Titan
Eloxx (ELOX) director Stephen Webster receives stock options for 13,587 shares - Stock Titan
ELOX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Eloxx Pharmaceuticals (ELOX) grants director 8,590 stock options - Stock Titan
ELOX Technical Analysis & Stock Price Forecast - Intellectia AI
ELOX PE Ratio & Valuation, Is ELOX Overvalued - Intellectia AI
ELOX News & Events - Intellectia AI
ELOX Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
Eloxx Pharmaceuticals, Inc.(NasdaqCM: ELOX) added to NASDAQ Composite Index - marketscreener.com
Form 424B4 Eloxx Pharmaceuticals, - StreetInsider
Eloxx Pharmaceuticals (ELOX) raises ~$66M via stock and pre‑funded warrants - Stock Titan
Eloxx Pharmaceuticals Offering Expected to Close June 10 >ELOX - Moomoo
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering - Pharmaceutical Executive
[EFFECT] Eloxx Pharmaceuticals, Inc. SEC Filing - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday SessionADITXT INC by Aditxt, Inc. (OTC:ADTX), AIM I - Benzinga
Eloxx Pharmaceuticals prices $66.0 million offering, uplists to Nasdaq - scanx.trade
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq - PR Newswire
Eloxx Pharmaceuticals, Inc. Earnings and Revenue – NASDAQ:ELOX - TradingView
Eloxx Pharmaceuticals Inc (ELOXD) Stock PDF (Updated: 2026/06/06) - GuruFocus
Domicilium files Schedule 13G/A reporting 4.9% stake in Eloxx (NASDAQ: ELOX) - Stock Titan
Domicilium Real Estate Fund III LP (ELOX) swaps 1.25M shares for pre-funded warrants - Stock Titan
Eloxx Pharmaceuticals (ELOX) targets $10–$12 offering and Nasdaq uplisting - Stock Titan
Total debt per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Working capital per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Book value per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Return on invested capital % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
EBITDA per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Free cash flow per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Debt to equity ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Net current asset value per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Asset turnover of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Operating cash flow per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Long term debt to total assets ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
CapEx per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Long term debt to total equity ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Debt to assets ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Return on assets % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Price to cash flow ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
EBIT per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Enterprise value of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
Eloxx Pharmaceuticals, Inc. Statistics – OTC:ELOXD - TradingView
Enterprise value to EBITDA ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
EBITDA margin % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView
1.17%
2.48%
大文字化:
|
ボリューム (24 時間):